目录
- Surgical management of cholangiocarcinoma
- Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes
- Pathology and molecular pathology of cholangiocarcinoma
- The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD
- A review of current adjuvant and neoadjuvant systemic treatments for cholangiocarcinoma and gallbladder carcinoma
- Use of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B